Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain LJPC message board posts where the ticker symbol LJPC has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest LJPC SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000920465-18-000019 Size: 6 KB
2018-06-01
8-K  Documents Current report, items 1.01, 2.02, 2.03, and 9.01
Acc-no: 0000920465-18-000018 (34 Act)  Size: 675 KB
2018-05-14 001-36282
18831925
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0000920465-18-000015 (34 Act)  Size: 1 MB
2018-05-10 001-36282
18823188
10-K/A  Documents [Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
Acc-no: 0000920465-18-000011 (34 Act)  Size: 638 KB
2018-04-30 001-36282
18791536
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0000215457-18-005552 (34 Act)  Size: 12 KB
2018-04-06 005-44849
18742150
CT ORDER  Documents Confidential treatment order
Acc-no: 9999999997-18-003881 (34 Act)  Size: 14 KB
2018-03-27 001-36282
18715828
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001012975-18-000298 Size: 8 KB
2018-03-26
SC 13D/A  Documents [Amend] General statement of acquisition of beneficial ownership
Acc-no: 0001214659-18-002241 (34 Act)  Size: 93 KB
2018-03-20 005-44849
18700531
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-020761 Size: 8 KB
2018-03-19
8-K  Documents Current report, items 1.01 and 9.01
Acc-no: 0001193125-18-086117 (34 Act)  Size: 259 KB
2018-03-19 001-36282
18696937
More LJPC SEC Filings


Related news from
Fri, 15 Jun 2018
18:39:50 +0000
2 Stable and 2 Speculative Biotech Stocks to Buy
Biotech stocks represent a peculiar conundrum. Successes here could spark revolutionary therapies that could end or at least alleviate human suffering. Thus, creating a list of biotech stocks to buy will always be a tough challenge.
Fri, 15 Jun 2018
11:09:00 +0000
Iovance Biotherapeutics and Three Additional Biotech Stocks on Our Research Desk's Radar
Stock Research Monitor: JAGX, JAZZ, and LJPC LONDON, UK / ACCESSWIRE / June 15, 2018 / If you want a free Stock Review on IOVA sign up now at www.wallstequities.com/registration . On Thursday, June 14, ...
Mon, 21 May 2018
12:25:00 +0000
Recent Analysis Shows Engility, La Jolla Pharmaceutical, Freshpet, At Home Group, Denny's, and SP Plus Market Influences — Renewed Outlook, Key Drivers of Growth
NEW YORK, May 21, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Engility ...
Thu, 17 May 2018
17:00:00 +0000
La Jolla Pharmaceutical Company Announces LJPC-401 Presentations at 23rd Congress of the European Hematology Association
SAN DIEGO, May 17, 2018-- La Jolla Pharmaceutical Company, a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering ...
Fri, 11 May 2018
11:05:00 +0000
Complimentary Stock Performance Review on La Jolla Pharma and Three Additional Biotech Industry Stocks
Gains were broad based as eight out of nine sectors finished the trading session in green. WallStEquities.com has initiated research reports on the following Biotechnology stocks: Immune Design Corp. (NASDAQ: IMDZ), ImmunoCellular Therapeutics Ltd (NYSE AMER: IMUC), La Jolla Pharmaceutical Co. (NASDAQ: LJPC), and Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX).
Fri, 11 May 2018
01:23:29 +0000
What Should We Expect From La Jolla Pharmaceutical Company’s (NASDAQ:LJPC) Earnings In The Next Couple Of Years?
The latest earnings release La Jolla Pharmaceutical Company’s (NASDAQ:LJPC) announced in December 2017 showed company earnings became less negative compared to the previous year’s level as a result of recentRead More...
Thu, 10 May 2018
23:53:47 +0000
La Jolla Pharmaceutical: 1Q Earnings Snapshot
On a per-share basis, the San Diego-based company said it had a loss of $2.22. The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research ...
Thu, 10 May 2018
20:46:00 +0000
La Jolla Pharmaceutical Company Announces $125 Million Royalty Financing Agreement with HealthCare Royalty Partners
La Jolla Pharmaceutical Company (LJPC) (La Jolla), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that it has closed a $125 million royalty financing agreement with HealthCare Royalty Partners (HCR). Under the terms of the agreement, La Jolla will receive $125 million in exchange for tiered royalty payments on worldwide net sales of GIAPREZA. Through December 31, 2021, the royalty rate will be a maximum of 10%.
Thu, 10 May 2018
20:45:00 +0000
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2018 and Recent Corporate Progress
SAN DIEGO, May 10, 2018-- La Jolla Pharmaceutical Company, a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering ...
Tue, 01 May 2018
21:15:00 +0000
CalciMedica Names Two Senior Executives to its Board of Directors
LA JOLLA, Calif., May 1, 2018 /PRNewswire/ -- CalciMedica announced that it named two independent members to its Board of Directors, Lakhmir Chawla, MD, currently Chief Medical Officer of La Jolla Pharmaceuticals Company (LJPC), and Christopher Krueger, JD, MBA, a co-founder and Chief Business Officer of Escalier Biosciences. The two new Board members bring extensive clinical development and financing/transaction experience, respectively, to CalciMedica as it advances its novel acute pancreatitis agent, CM4620, through clinical development.
Fri, 30 Mar 2018
12:00:00 +0000
[$$] 3 Biotech Stocks a Pro Is Buying Now
The last time we checked in with Joseph Edelman, the founder, chief executive and portfolio manager of Perceptive Advisors and its hedge fund, Perceptive Life Sciences, he was buying stocks ahead of the new year. Edelman famously oversaw a 4% gain in 2016 as the biotech sector tumbled 20%. What stocks are Edelman, and his chief investment officer, Adam Stone, buying now?
Fri, 23 Mar 2018
11:40:00 +0000
Market Trends Toward New Normal in La Jolla Pharmaceutical, AquaVenture, Duluth, Community Bank System, Cubic, and TrustCo Bank Corp NY — Emerging Consolidated Expectations, Analyst Ratings
NEW YORK, March 23, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
Thu, 22 Mar 2018
20:01:00 +0000
La Jolla Pharmaceutical Company Announces Launch of GIAPREZA™ (angiotensin II) in the United States
SAN DIEGO, March 22, 2018-- La Jolla Pharmaceutical Company today announced that GIAPREZA™, injection for intravenous infusion, is now commercially available. In December 2017, GIAPREZA was approved by ...
Fri, 23 Feb 2018
10:02:14 +0000
La Jolla Pharmaceutical posts 4Q loss
On a per-share basis, the San Diego-based company said it had a loss of $1.74. The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was ...



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "I have been a VF subscriber for one year and have found the members here generally to be informed, intelligent, articulate people of good will. The knowledge I've gathered has been well worth the price of tuition, and the subscription fee has been repaid many-fold in investment gains." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards